C3 degradation products (C3d) in normal pregnancyJENKINS, J. S; POWELL, R. J.Journal of clinical pathology. 1987, Vol 40, Num 11, pp 1362-1363, issn 0021-9746Article

CRITICAL ROLE OF THE CONVERSION OF THE THIRD COMPLEMENT COMPONENT C3(BETA 1C/BETA 1A) FOR ITS IMMUNOCHEMICAL QUANTITATION.SPATH P; GABL F.1976; CLIN. CHIM. ACTA; PAYS-BAS; DA. 1976; VOL. 73; NO 1; PP. 171-175; BIBL. 33 REF.Article

KINETISCHE IMMUNOLOGISCH-TURBIDIMETRISCHE C3-BESTIMMUNG MIT EINEM FAST ANALYZER. = DETERMINATION CINETIQUE IMMUNOTURBIDIMETRIQUE DE C3 AVEC UN ANALYSEUR RAPIDEEBELING H.1978; J. CLIN. CHEM. CLIN. BIOCHEM.; GERM.; DA. 1978; VOL. 16; NO 3; PP. 191-195; ABS. ANGL.; BIBL. 6 REF.Article

Generation of three different fragments of bound C3 with purified factor I or serum. II: Location of linding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutininROSS, G. D; NEWMAN, S. L; LAMBRIS, J. D et al.The Journal of experimental medicine. 1983, Vol 158, Num 2, pp 334-352, issn 0022-1007Article

Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and membrane osmotic fragilityINADA, Y; KAMIYAMA, M; KANEMITSU, T et al.Journal of clinical & laboratory immunology. 1983, Vol 12, Num 2, pp 97-103, issn 0141-2760Article

Conditions for the generation of high serum levels of C3DP = Conditions favorables à la production de taux élevés sériques de C3DPWHITE, P. J; HOCH, S. O.Cancer biochemistry biophysics. 1982, Vol 6, Num 1, pp 19-22, issn 0305-7232Article

CLINICAL APPLICATIONS OF IMMUNOFIXATION: DETECTION AND QUANTITATION OF COMPLEMENT ACTIVATIONWHICHER JT; HIGGINSON J; RICHES PG et al.1980; J. CLIN. PATHOL.; ISSN 0021-9746; USA; DA. 1980; VOL. 33; NO 8; PP. 781-785; BIBL. 19 REF.Article

Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (α2D), and C3gDAVIS, A. E. III; HARRISON, R. A; LACHMANN, P. J et al.The Journal of immunology (1950). 1984, Vol 132, Num 4, pp 1960-1966, issn 0022-1767Article

A hemolytic method for the measurement of nephritic factorWEST, Clark D.Journal of immunological methods. 2008, Vol 335, Num 1-2, pp 1-7, issn 0022-1759, 7 p.Article

Mechanisms for eosinophil degranulation; release of the eosinophil cationic proteinWINQVIST, I; OLOFSSON, T; OLSSON, I et al.Immunology (Oxford). 1984, Vol 51, Num 1, pp 1-8, issn 0019-2805Article

Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its o-antigen lengthGROSSMAN, N; LEIVE, L.The Journal of immunology (1950). 1984, Vol 132, Num 1, pp 376-385, issn 0022-1767Article

Polymer agglutination-based piezoelectric immunoassay for the determination of complement IIICHU, X; SHEN, G.-L; YU, R.-Q et al.Analyst (London. 1877. Print). 1996, Vol 121, Num 11, pp 1689-1694, issn 0003-2654Conference Paper

C3d,g in normal human epidermal basement membraneBASSET-SEGUIN, N; YANCEY, K. B; JUHLIN, L et al.Acta dermato-venereologica. 1990, Vol 70, Num 3, issn 0001-5555, p. 273Article

The microbial content and complement C3 cleaving capacity of comedones in acne vulgarisLEEMING, J. P; INGHAM, E; CUNLIFFE, W. J. J et al.Acta dermato-venereologica. 1988, Vol 68, Num 6, pp 468-473, issn 0001-5555Article

Inmunoglobulinas séricas y fracciones C₃, C₄ del complemento en el psoriasis = Immunoglobulines sériques et fractions C₃, C₄ du complément dans le psoriasis = Seric immunoglobulins and fractions C₃ C₄ of complement in psoriasisORTEGA RESINAS, M; HERRERA SAVAL, A; LOPEZ ELORZA, F et al.Actas dermo-sifiliográficas (Ed. impresa). 1988, Vol 79, Num 6, pp 551-554, issn 0001-7310Article

Crossed immunoelectrophoresis for the third complement component in dengue hemorrhagic fever. II: In vitro activation by Dengue viral antigenCHURDBOONCHART, V; BHAMARAPRAVATI, N; YORKSAN, S et al.The American journal of tropical medicine and hygiene. 1984, Vol 33, Num 6, pp 1239-1247, issn 0002-9637Article

Molecular characterization of complement components (C3, C4, and factor B) in human salivaANDOH, A; FUJIYAMA, Y; KIMURA, T et al.Journal of clinical immunology. 1997, Vol 17, Num 5, pp 404-407, issn 0271-9142Article

Effect of iodinated contrast media on a radioimmunoassay of C₃aEATON, S; TSAY, H. M; YOST, F et al.Clinical chemistry (Baltimore, Md.). 1987, Vol 33, Num 8, issn 0009-9147, 1470Article

Pregnancy-associated plasma protein A (PAPP-A) specifically inhibits the third component of human complement (C₃)BISCHOF, P; GEINOZ, A; HERRMANN, W. L et al.Placenta (Eastbourne). 1984, Vol 5, Num 1, pp 1-8, issn 0143-4004Article

Histiocytosis-X cells express C3b, C3d, and C3bi receptor (CR1, CR2, and CR3) antigensBIEBER, T; HANAU, D; HEID, E et al.Archives of dermatological research (Print). 1985, Vol 277, Num 6, pp 496-498, issn 0340-3696Article

Une nouvelle étiologie des épisclérites: les néphropathies à IgA et/ou C3 isolé = Episcleritis new etiology: IgA and/or isolated C₃ nephropathySIRBAT, D; SAUDAX, E; DE LIGNY, B. H et al.Journal français d'ophtalmologie. 1983, Vol 6, Num 11, pp 921-925, issn 0181-5512Article

Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3PALARASAH, Yaseelan; SKJODT, Karsten; BRANDT, Jette et al.Journal of immunological methods. 2010, Vol 362, Num 1-2, pp 142-150, issn 0022-1759, 9 p.Article

Enzyme-independent, orientation-selective conjugation of whole human complement C3 to protein surfacesMITCHELL, Daniel A; ILYAS, Rebecca; DODDS, Alister W et al.Journal of immunological methods. 2008, Vol 337, Num 1, pp 49-54, issn 0022-1759, 6 p.Article

Complement in type 1 (insulin-dependent) diabetesSENALDI, G; MILLWARD, B. A; HUSSEIN, M. J et al.Diabetologia (Berlin). 1987, Vol 30, Num 10, issn 0012-186X, 823Article

Immune complexes in retinitis pigmentosaHEREDIA, C. D; HUGUET, J; COLS, N et al.British journal of ophthalmology. 1984, Vol 68, Num 11, pp 811-814, issn 0007-1161Article